ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fracture

Intensive, Personalized Learning

Susan Bernstein  |  August 28, 2019

During the 2019 ACR/ARP Annual Meeting, the new Meet the Professor Workshops and sessions will feature hands-on training on state-of-the-art topics…

Filed under:Education & TrainingProfessional Topics Tagged with:2019 ACR/ARP Annual MeetingEducationeducation and training

Osteoporosis Drugs Don’t Reduce Overall Mortality

Megan Brooks  |  August 21, 2019

NEW YORK (Reuters Health)—Anti-fracture medications do not reduce overall mortality in older patients with osteoporosis, according to an updated systematic review and meta-analysis. “This meta-analysis suggests drug treatments, including treatment with bisphosphonates, for osteoporosis should be recommended only for the prevention of fracture and not for any additional reduction in mortality,” researchers write in JAMA…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:FracturesmortalityOsteoporosisosteoporosis treatments

Tanezumab’s Phase 3 Results for OA

Michele B. Kaufman, PharmD, BCGP  |  June 25, 2019

In a recent study, tanezumab proved safe and effective in the treatment of knee and hip osteoarthritis…

Filed under:AnalgesicsDrug Updates Tagged with:hipkneeKnee Osteoarthritis (OA)osteoarthritis (OA)Paintanezumab

ACR Pushes for Increased DXA Reimbursement

Linda Childers  |  June 19, 2019

Broken hips are among the most serious injuries incurred by older adults, and many fractures are preventable. According to the Centers for Disease Control and Prevention (CDC), approximately 300,000 people over the age of 65 are hospitalized each year for hip fractures, with women (who have lower bone density than men) experiencing three-quarters of all…

Filed under:Legislation & Advocacy Tagged with:Dr. Chris Phillipsdual-energy X-ray absorptiometry (DXA)DXA reimbursement cutsFractureship fractureIncreasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)Ken Saag

U.S. Supreme Court Tosses Ruling Against Merck on Fosamax Osteoporosis Drug

Andrew Chung  |  May 22, 2019

WASHINGTON (Reuters)—On May 20, the U.S. Supreme Court threw out a lower court ruling that had revived hundreds of lawsuits accusing Merck & Co. of failing to properly warn patients of debilitating thigh-bone fractures as a result of taking its osteoporosis drug alendronic acid (Fosamax). The nine justices unanimously directed the Philadelphia-based 3rd U.S. Circuit…

Filed under:ConditionsDrug UpdatesLegal UpdatesOsteoarthritis and Bone Disorders Tagged with:alendronic acidFosamaxfracture riskFracturesMerck & CoOsteoporosisosteoporosis treatmentsU.S. Supreme Court

Ultrasound Image Review: A 30-Year-Old Woman with Left Foot Pain

Eugene Kissin, MD, RhMSUS, & Catherine Bakewell, MD, RhMSUS  |  May 17, 2019

Presentation A 30-year-old woman presented to her rheumatologist for left foot pain of three weeks’ duration. She was followed for systemic lupus erythematosus manifesting in arthritis and hemolytic anemia, as well as anti-nuclear antibody and Smith antibody positivity, and was treated with hydroxychloroquine and prednisone in the 2.5–10 mg per day range. She was symptom…

Filed under:Conditions Tagged with:FracturesGlucocorticoidsstress fractureUltrasound

ACR Leaders to Meet with Members of Congress

From the College  |  May 2, 2019

On May 16, ACR and ARP leaders serving on the Board of Directors, Affiliate Society Council, Government Affairs Committee, Committee on Rheumatologic Care, RheumPAC and Insurance Subcommittee will go to Capitol Hill to advocate on behalf of the College’s membership and our patients. The group represents 31 states and the District of Columbia, and will…

Filed under:ConditionsFrom the CollegeLegislation & AdvocacyOsteoarthritis and Bone DisordersWorkforce Tagged with:Capitol Hill fly-inDepartment of Defense (DoD)Ensuring Seniors’ Timely Access to Care Act of 2019Increasing Access to Osteoporosis Testing for Medicare Beneficiaries Act (S. 283)OsteoporosisSafe Step Act of 2019 (H.R. 2279)Strengthening our Pediatric Workforce Act (H.R. 1656)

FDA Approves New Osteoporosis Medication

Michele B. Kaufman, PharmD, BCGP  |  April 23, 2019

Romosozumab-aqqg has been approved in the U.S. for treating postmenopausal women with osteoporosis at high risk of fracture…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:FDAOsteoporosisosteoporosis treatmentspostmenopausalpostmenopausal womenromosozumab-aqqgU.S. Food and Drug Administration (FDA)

Tips for Interdisciplinary Pain Management in Older Patients

Susan Bernstein  |  April 15, 2019

CHICAGO—Rheumatology healthcare providers should embrace collaborative approaches to manage chronic musculoskeletal pain in older adult patients, including models of care that involve multiple providers, patients and their caregivers. That was the message delivered by two speakers in the Interdisciplinary Management of Chronic Musculo­skeletal Pain in Older Adults session at the 2018 ACR/ARHP Annual Meeting. “As…

Filed under:AnalgesicsConditions Tagged with:2018 ACR/ARHP Annual MeetingbiopsychosocialcollaborationExerciseinterdisciplinaryPain Managementstepped care

Dietary Calcium Intake Not Associated with Bone Loss

Lara C. Pullen, PhD  |  April 15, 2019

Postmenopausal women are often told to consume more than 1,500 mg of calcium daily to reach neutral bone balance. But new research suggests this recommendation should be revised, finding no connection between dietary calcium intake and postmenopausal bone loss…

Filed under:ConditionsOsteoarthritis and Bone Disorders Tagged with:bone lossbone mineral density (BMD)calciumDietFracturesOsteoporosis

  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 44
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences